[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100645143":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":55,"collaborators":24,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":24,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":24,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":24,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A (Nd:YAG Group):","EXPERIMENTAL","Patients will receive Nd:YAG laser (1064 nm) + injection sclerotherapy (CLaCS).",[13],"Device: Nd:YAG laser",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B (Diode Group)","Patients will receive Diode laser (980 nm) + injection sclerotherapy (CLaCS).",[18],"Drug: Diode laser",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DEVICE","Nd:YAG laser",[9],null,{"type":26,"name":27,"description":16,"armGroupLabels":28,"otherNames":24},"DRUG","Diode laser",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Mohamed A Hagag, MD","CONTACT","00201126560324","hagagmohamed@med.asu.edu.eg",[36],{"facility":5,"status":37,"city":38,"state":24,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Cairo","11591","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.24967,30.06263,{"lat":46,"lon":45},[49,50,53],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},{"name":51,"role":52,"phone":24,"phoneExt":24,"email":24},"Ahmed G Abdellattif, MD","PRINCIPAL_INVESTIGATOR",{"name":54,"role":52,"phone":24,"phoneExt":24,"email":24},"Mina G Basta, MD",{"type":52,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"MohamedAhmed","Lecturer of Vascular Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt.","100645143","ndyag-laser-combined-with-injection-sclerotherapy-versus-diode-laser-in-the-treatment-of-reticular-veins-and-telangiectasias-using-clacs-technique-100645143",false,"NCT07678697","Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique","Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique","Inclusion Criteria:\n\n* Patients aged 18-60 years.\n* Both sexes.\n* Presence of reticular veins and\u002For telangiectasias (CEAP classification C1).\n* Fitzpatrick skin types II-V.\n* Patients seeking cosmetic treatment.\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* History of deep vein thrombosis.\n* Coagulation disorders.\n* Allergy to sclerosant agents.\n* Active skin infection at treatment site.\n* Previous treatment of target veins within 6 months.\n* Great saphenous vein or short saphenous vein incompetence.\n* Deep venous insufficiency or thrombosis.\n* Abnormal venous duplex findings.","ALL","18 Years","60 Years",{"count":69,"type":70},80,"ESTIMATED","INTERVENTIONAL",[73],"NA","This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.",[76,77,78,79,80,81],"Nd:YAG Laser","Sclerotherapy","Diode Laser","Reticular Veins","Telangiectasias","CLaCS Technique","2026-06-25",{"date":84,"type":85},"2026-07-01","ACTUAL",{"date":87,"type":85},"2026-06-01",{"date":89,"type":70},"2026-12-01",{"name":5,"class":6},1]